Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineNo recent work listed

Lin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3821-7147; OpenAlex author ID A5100412869. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers

Papers 3

  1. FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. Co-author DOI 10.1038/s41419-022-05213-w↗
  2. MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway. Co-author DOI 10.1186/s12967-022-03749-1↗
  3. Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer. Last author DOI 10.1016/j.bbrc.2015.05.108↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kun Cai · 2 shared papers, 2022 · strength 0.36
  2. Zhiwei He · 2 shared papers, 2022 · strength 0.36
  3. Dijie Zheng · 1 shared paper, 2022 · strength 0.19
  4. Chao Yu · 1 shared paper, 2022 · strength 0.19
  5. Shiyu Chen · 1 shared paper, 2022 · strength 0.17
  6. Chao Yu · 1 shared paper, 2022 · strength 0.17
  7. Cheng-Yi Sun · 1 shared paper, 2022 · strength 0.17
  8. Yong Bian · 1 shared paper, 2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.